About Vuja De Sciences
Vuja De Sciences is a company based in Hoboken (United States) founded in 2017. Vuja De Sciences has raised $3.94 million across 10 funding rounds. Vuja De Sciences offers products and services including Discovery Platform. Vuja De Sciences operates in a competitive market with competitors including SpringWorks Therapeutics, QSAM Biosciences, ECM Therapeutics, Taithera and Atlanthera, among others.
- Headquarter Hoboken, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Vuja De Sciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.94 M (USD)
in 10 rounds
-
Latest Funding Round
$370 K (USD), Seed
Oct 04, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vuja De Sciences
Vuja De Sciences offers a comprehensive portfolio of products and services, including Discovery Platform.
Platform identifies drugs targeting metastatic endurance in tumors.
People of Vuja De Sciences
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Vuja De Sciences
Vuja De Sciences has successfully raised a total of $3.94M across 10 strategic funding rounds. The most recent funding activity was a Seed round of $370 thousand completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Vuja De Sciences
Investment portfolio details for Vuja De Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vuja De Sciences
Detailed financials for Vuja De Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vuja De Sciences Comparisons
Peer comparison for Vuja De Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vuja De Sciences
Vuja De Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SpringWorks Therapeutics, QSAM Biosciences, ECM Therapeutics, Taithera and Atlanthera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecule therapeutics are developed for cancer and rare diseases.
|
|
| Locked | Locked | Locked |
Developer of nuclear medicines for the treatment of bone cancer treatment & bone marrow ablation
|
|
| Locked | Locked | Locked |
Diagnostic and therapeutic products from extracellular matrix are developed.
|
|
| Locked | Locked | Locked |
Nanomedicine platform for targeted bone drug delivery is developed.
|
|
| Locked | Locked | Locked |
Small molecule drugs for bone diseases and tumors are developed.
|
Detailed competitors of Vuja De Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vuja De Sciences
Complete news archive for Vuja De Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vuja De Sciences
Vuja De Sciences was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Vuja De Sciences is headquartered in Hoboken, United States. It is registered at Hoboken, New Jersey, United States.
Vuja De Sciences is a funded company, having raised a total of $3.94M across 10 funding rounds to date.
Vuja De Sciences was founded in 2017 and is based in Hoboken, United States. Focus is placed on the biotechnology sector, specifically oncology, where therapies aimed at preventing cancer metastasis and recurrence are developed. A lead candidate, VUJ-100, is advanced using a proprietary platform that demonstrates anti-metastatic activity across models, including metastatic osteosarcoma and other cancers. Operations involve research and development for these therapeutic applications.
Vuja De Sciences's top competitors include SpringWorks Therapeutics, QSAM Biosciences and Taithera.
Vuja De Sciences offers Discovery Platform.